Insider Holders & Insider Ownership - Adaptive Biotechnologies Corp (ADPT)

List of insiders holdings for Adaptive Biotechnologies Corp:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time		Shares Owned
Directly
Indirectly		Total
Shares Owned		Filing
VIKING GLOBAL PERFORMANCE LLC
Viking Global Equities LP
Viking Global Equities II LP
VGE III Portfolio Ltd.
Viking Global Equities Master Ltd.
Viking Long Fund GP LLC
Viking Long Fund Master Ltd.
HALVORSEN OLE ANDREAS
Ott David C.
Shabet Rose Sharon
10% Owner		2019-06-26 18:03:460
38,156,607		38,156,607Form 3
VIKING GLOBAL INVESTORS LP
Viking Global Opportunities Illiquid Investments Sub-Master LP
Viking Global Opportunities Portfolio GP LLC
Viking Global Opportunities GP LLC
HALVORSEN OLE ANDREAS
Ott David C.
Shabet Rose Sharon
10% Owner		2024-02-14 10:23:1929,993,708
0		29,993,708Form 13G
VIKING GLOBAL INVESTORS LP
VIKING GLOBAL PERFORMANCE LLC
Viking Global Equities II LP
Viking Global Equities Master Ltd.
Viking Long Fund GP LLC
Viking Long Fund Master Ltd.
HALVORSEN OLE ANDREAS
Ott David C.
Shabet Rose Sharon
10% Owner		2024-02-14 10:23:1929,993,708
0		29,993,708Form 13G
ROBINS CHAD M
CEO and Chairman		2024-03-06 19:40:212,576,701
0		2,576,701Form 4
ROBINS HARLAN S
Chief Scientific Officer		2024-03-06 19:41:081,021,180
0		1,021,180Form 4
NOLAN SEAN PATRICK
Chief Technology Officer		2019-06-26 18:40:52750,000
0		750,000Form 3
GOEL DAVID E.
Matrix Capital Management Company LP
See Remarks		2024-11-13 09:00:21650,000
0		650,000Form 13G
PETERSON TYCHO
Chief Financial Officer		2024-03-06 19:40:45531,553
0		531,553Form 4
BENZENO SHARON
Chief Commercial Ofc Imm Med		2024-03-06 19:42:00526,964
0		526,964Form 4
RUBINSTEIN JULIE
President		2024-03-06 19:41:33472,754
0		472,754Form 4
LO FRANCIS
Chief People Officer		2024-03-06 19:42:24403,769
2,500		406,269Form 4
BOBULSKY SUSAN
Chief Commercial Officer, MRD		2024-10-10 17:47:53253,290
0		253,290Form 4
SOOD NITIN
Chief Commercial Officer, MRD		2023-08-08 16:53:22214,808
0		214,808Form 4
ADAMS R MARK
Chief Operating Officer		2023-04-12 18:04:08175,361
0		175,361Form 4
NEUPERT PETER M
Director		2024-03-13 17:55:24169,296
0		169,296Form 4
HERSHBERG ROBERT
Director		2024-03-06 19:45:02155,340
0		155,340Form 4
SANG CHARLES
SVP, External Affairs		2020-12-11 21:00:07155,000
0		155,000Form 4
PISKEL KYLE
Chief Financial Officer		2024-05-17 18:35:48154,578
0		154,578Form 4
Taylor Stacy L
SVP and General Counsel		2024-08-23 16:27:19139,365
0		139,365Form 4
Palaniappan Jyoti
SVP, Diagnostics, T-Detect		2021-07-19 21:00:28113,551
0		113,551Form 4
OWEN KATEY EINTERZ
Director		2024-03-06 19:45:53105,279
0		105,279Form 4
Pellini Michael J
Director		2024-03-06 19:46:07102,340
0		102,340Form 4
THORSEN HENNING
SVP, Commercial Operations		2021-05-19 20:00:11101,714
0		101,714Form 4
Cohen Chad M
Chief Financial Officer		2021-12-23 21:00:16101,604
0		101,604Form 4
GRIFFIN MICHELLE RENEE
Director		2024-03-06 19:43:5999,999
0		99,999Form 4
Trigg Leslie
Director		2023-03-08 20:05:4049,236
0		49,236Form 4
Conroy Kevin T
Director		2023-03-08 20:05:5646,297
0		46,297Form 4
HILL NANCY LOUISE
EVP, Operations & Program Mana		2021-01-21 21:00:1237,000
1,200		38,200Form 4
BALDO LANCE
Chief Medical Officer		2022-03-10 18:00:1617,171
0		17,171Form 4
ZOLTNERS ANDRIS A
Director		2020-02-18 07:05:258,888
0		8,888Form 4
DOBMEIER ERIC
Director		2021-02-17 20:01:215,263
0		5,263Form 4